GPCR Stock: Structure Therapeutics Inc. Stock Price, Analysis & Insights

Get live GPCR stock price $41.69, comprehensive Structure Therapeutics Inc. stock analysis, charts, news, and expert forecast. Real-time GPCR stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

41.69

1.07%Today

GPCR • Structure Therapeutics Inc. • NASDAQ Global Market • Healthcare

Market Cap

2.40B

Volume

431.67K

52W High

94.90

52W Low

15.80

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Structure Therapeutics Inc., an international biopharmaceutical company currently in its clinical development phase, is committed to creating and providing groundbreaking oral therapies for various chronic diseases that lack adequate treatment option...

Contact Information

Website: https://structuretx.com
Address: 611 Gateway Boulevard
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Lower volatility stock (Beta: -1.42) may provide portfolio stability

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Structure Therapeutics Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Structure Therapeutics Inc.
⚠Investors should consider how Structure Therapeutics Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

2.40B

P/E Ratio (TTM)

-15.67

Beta

-1.42

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare GPCR with peer companies:

AbCellera Biologics Inc. (ABCL)

Price: $5.15
Market cap: 1.57B

Celldex Therapeutics, Inc. (CLDX)

Price: $29.47
Market cap: 1.96B

Edgewise Therapeutics, Inc. (EWTX)

Price: $33.31
Market cap: 3.58B

Galapagos N.V. (GLPG)

Price: $27.98
Market cap: 1.84B

Liquidia Corporation (LQDA)

Price: $66.45
Market cap: 5.91B

Mesoblast Limited (MESO)

Price: $13.98
Market cap: 1.80B

Nuvation Bio Inc. (NUVB)

Price: $4.68
Market cap: 1.62B

Ocular Therapeutix, Inc. (OCUL)

Price: $8.40
Market cap: 1.84B

uniQure N.V. (QURE)

Price: $26.21
Market cap: 1.65B

Viridian Therapeutics, Inc. (VRDN)

Price: $15.68
Market cap: 1.41B

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.